Short-term Metabolic Effects of Ketosteril® Supplemented Low Protein Diet in Pre-dialysis Chronic Kidney Disease (CKD) Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

March 30, 2017

Primary Completion Date

April 27, 2018

Study Completion Date

May 2, 2018

Conditions
Renal Insufficiency, Chronic
Interventions
DRUG

Ketosteril®

Patients will be randomised to receive isonitrogenous and isocaloric LPD providing 0.6 g protein/kg BW/day and an energy intake of 30-35 kcal/kg BW/day with (test group) or without (control group) intake of Ketosteril® (1 tablet/5 kg BW/day). The control group will get additional food protein to balance the nitrogen content of Ketosteril® The mainly vegetarian diet will be maintained for 10 days.

Trial Locations (1)

140 59

Thomayer Hospital Clinical - Pharmacology Unit (CPU), Prague

All Listed Sponsors
collaborator

EastHORN Clinical Services in CEE

UNKNOWN

collaborator

MLM Medical Labs GmbH

INDUSTRY

collaborator

ALS Czech Republic, s.r.o.

UNKNOWN

collaborator

PCG Clinical Services AB

UNKNOWN

lead

Fresenius Kabi

INDUSTRY